Financing type:  underwritten prospectus offering

Gross proceeds:  $63.48-million

Offering:  24.61 million charity flow-through (CFT) listed shares; 4.37 million listed shares

Offering price:  $2.29 per CFT listed share; $1.63 per listed share

Overallotment option:  The underwriters may purchase a maximum of 3.21 million CFT listed shares for overallotment purposes. As of June 12, 2025, such option had been exercised in full and 3.21 million CFT listed shares have been issued thereunder. All information presented herein includes such exercise.

Public disclosure:  Refer to the prospectus supplement dated May 29, 2025, and the company's news releases dated May 27, 2025, May 28, 2025, June 3, 2025, and June 12, 2025.